Skip to content
The Nexus
DossierENTITY

UCSF

Coverage of UCSF in the Nexus archive.

Earliest in view: May 21 · 16:27 UTCMost recent: Jul 8 · 12:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 8 · 12:00 UTCCALMATTERS
    Therapy in a tent: The healthcare many homeless Californians need but aren’t getting

    Homeless Californians face significant mental health challenges like anxiety and depression but lack access to adequate care. Therapists are providing services in unconventional settings such as tents and shelters, but demand far exceeds capacity. A UCSF study found 48% of homeless individuals report serious depression and 51% report anxiety.

  • HEALTHJun 29 · 21:01 UTCCBS NEWS
    Millions of women with menopause barred from hormone replacement therapy because of health risk

    Hormone replacement therapy is seeing increased prescriptions for menopause symptoms, but millions of women, including breast cancer survivors, cannot take HRT due to medical risks. Dr. Mindy Goldman, affiliated with Midi Health and UCSF, discusses the issue with CBS News.

  • HEALTHJun 1 · 17:12 UTCMISSION LOCAL SF
    UCSF interns, residents kick off 10 days of protest for union contract

    UCSF interns and residents are protesting for 10 days at 17 hospitals to demand a new union contract. The action involves physicians in training advocating for improved working conditions.

  • HEALTHMay 27 · 05:38 UTCNBC BAY AREA
    Rotavirus in the Bay Area: How it spreads and how to protect yourself

    A late-season rotavirus is spreading in the Bay Area, detected in wastewater at medium to high levels in cities like San Francisco and San Jose. The virus spreads through contaminated surfaces and poor hand hygiene, particularly in daycare settings, but can be prevented with vaccines and thorough handwashing.

  • HEALTHMay 21 · 16:27 UTCSTAT NEWS
    STAT+: Immunovant shares surge on arthritis trial data

    Immunovant shares surge following positive arthritis trial data. UCSF researchers have submitted an FDA application for a prenatal gene therapy targeting a severe neurodegenerative disorder affecting young children. FDA leadership instability is causing investor concern and impacting rare disease drug development.

UCSF · Dossier · The Nexus